Meagan Adamson
Family · Fairfax, VANPI 1790061091
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,402 of the $34,440 with a category attached, or 62.1%. 17 manufacturers reported payments, led by Biogen at 34.9% of the total. Reporting peaked in 2021 at $12,268 and has fallen 96.3% since, to $455 in 2025. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $291.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$12K
- Sanofi$9K
- Genentech USA, Inc.$4K
- Bristol Myers Squibb$3K
- E.r. Squibb & Sons, L.L.C.$3K
- TG Therapeutics, Inc.$3K
- plus $1K from 11 others
What the payments were for
- Consulting fees$10,61531%
- Speaking & faculty fees$21,40262%
- Food & beverage$2,4127%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 24 | $12,005 |
| Sanofi | 12 | $8,798 |
| Genentech USA, Inc. | 12 | $4,482 |
| Bristol Myers Squibb | 7 | $2,766 |
| E.r. Squibb & Sons, L.L.C. | 4 | $2,724 |
| TG Therapeutics, Inc. | 9 | $2,590 |
| Novartis | 36 | $617 |
| EMD Serono, Inc. | 4 | $219 |
| Banner Life Sciences, LLC | 2 | $47 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| AstraZeneca | 1 | $25 |
| Amgen | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,440 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RebifInterferon Beta-1a/Albumin | 25 | $283,247 |
| BetaseronInterferon Beta-1b | 22 | $205,337 |
| Kesimpta PenOfatumumab | 17 | $165,556 |
| GilenyaFingolimod Hcl | 12 | $126,680 |
| Teriflunomide | 53 | $103,232 |
| Dimethyl Fumarate | 20 | $59,061 |
| GlatopaGlatiramer Acetate | 15 | $47,783 |
| Dalfampridine ErDalfampridine | 34 | $16,939 |
| Aimovig AutoinjectorErenumab-Aooe | 19 | $13,831 |
| MyrbetriqMirabegron | 12 | $5,865 |
| Baclofen | 99 | $4,391 |
| Modafinil | 26 | $2,843 |
| Pregabalin | 41 | $2,653 |
| FingolimodFingolimod Hcl | 12 | $2,568 |
| Gabapentin | 143 | $2,502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| EMD Serono, Inc.Rebif | $219 | $283,24725 claims |
| NovartisGilenya | $617 | $126,68012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Fairfax
- Christine HelouFairfax$28K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.